Takis, a biotechnology company based in Rome, Italy, has over 10 years of experience in drug discovery. We have made significant contributions to validating new targets for treating chronic viral diseases and cancer, as well as to several IND/CSA filings in the areas of virology and oncology. Our team is also recognized for developing innovative technologies aimed at enhancing gene transfer in vivo, regulating gene expression, and improving immunogenicity.
Takis primarily focuses on developing therapeutic antibodies and cancer vaccines targeting antigens associated with infectious disease and tumors. To know more
